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 Millions of people around the world are affected by diarrheal diseases 
every year.  Shigella flexneri is a gram-negative facultative anaerobic bacillus 
that is the causative agent of shigellosis, a severe form of bacillary dysentery.  
The largest number of cases are found in developing countries due to endemic 
infections by Shigella spp, however, approximately 14,000 cases a year are 
reported in the United States to the Centers for Disease Control and Prevention 
(http://www.cdc.gov/nczved/dfbmd/disease_listing/shigellosis_gi.html).  This 
number is thought to be significantly underestimated, and the actual number may 
be as much as twenty times more since infections with Shigella spp. not required 
to be reported and there are many undiagnosed cases 
(http://www.cdc.gov/nczved/dfbmd/disease_listing/shigellosis_gi.html).  The large 
number of people affected around the world, the many deaths it is responsible for 
and the emergence of antibiotic drug resistant strains have led to increased 






 Kiyoshi Shiga was the first to characterize the etiological agent of bacillary 
dysentery while studying the sekiri (dysentery) outbreaks in Japan in 1897 
(Shiga, 1897). While working at the Institute of Infectious Diseases in Japan, he 
isolated bacilli from the stools of thirty-six dysentery patients under observation 
(Shiga, 1897).  This bacillus was gram-negative, a dextrose fermenter, had a 
negative indole reaction and was unable to form acid from mannitol (Niyogi, 
2005).  He found this bacillus also caused diarrhea when it was subcultured and 
fed to dogs (Niyogi, 2005).  While continuing to characterize the organism, Shiga 
first named it Bacillus dysenteriae (Shiga, 1906).  Soon after Shiga’s initial 
observation of Bacillus dysenteriae, other investigators were working to 
characterize this newly discovered organism.  Several of these investigators 
discovered organisms morphologically and biochemically similar to the Bacillus 
dysenteriae reported by Shiga that caused similar disease in patients (Flexner, 
1900) (Kruse, 1900). 
 During the next forty years, the genus Shigella grew to include three 
additional groups of related organisms, S. flexneri, S. boydii, and S. sonnei along 
with S. dysenteria, all named in honor of their lead workers, Flexner, Boyd, 
Sonne and Shiga (Hale, 1991).  The genus Shigella was first named in the 1930 
edition of Bergey’s Manual of Determinative Bacteriology, but was officially 
adopted by the 1952 Congress of the International Association of Microbiologists 
(Shigella Commission) (Niyogi, 2005).  The bacteria Shiga initially discovered 




The genus Shigella currently includes the four species previously named and 
belongs to the family Enterobacteriaceae.  Biochemical and serological 
differences are the basis of the classification of the four species, with each 
composing a different serogroup, A, B, C and D (Niyogi, 2005). 
 Beginning in the 1950’s, shigellae investigators shifted their focus to 
determining the mechanism of virulence.  The host range of Shigella is small, 
consisting of humans and other higher primates; however, in the 1950s animal 
model was discovered when the corneal epithelium of guinea pigs were infected 
with Shigella spp. (Sereńy test) (Sereńy, 1957).  Not long after in the early 1960s, 
Shigella spp. were shown to possess the ability to grow in cultured mammalian 
cells (Gerber and Watkins, 1961). 
 Into the 1960s, many researchers believed the release of toxins by 
shigellae when adhered to the surface of intestinal epithelial cells was its main 
source of pathogenicity (Watkins, 1960).  However, work done by LaBrec et al. 
established that shigellosis required the invasion of the colonic epithelium 
(LaBrec et al., 1964).  They observed that ulceration and penetration of the 
epithelial cells of the colon and lamina propia resulted when guinea pigs were fed 
virulent strains of S. flexneri (LaBrec et al., 1964). 
 In the 1980s, Sansonetti and his colleagues discovered that a large 
plasmid was the genetic basis for the pathogensis of the shigellae (Sansonetti, 
1981). They showed that a loss of this plasmid made the organism unable to 
invade cultured mammalian cells or induce keratoconjunctivitis, inflammation of 




This large, 200-kb plasmid has been shown to contain the necessary genes 
required for invasion by Shigella and it has been found in all four species 
(Buchrieser et al., 2000).  Currently, many Shigella researchers are focused on 
the characterization of this large plasmid to better understand the genes it 
contains and the proteins it encodes. 
 
Epidemiology and Pathology 
 Shigellosis is a common disease of humans with infection mostly limited to 
the intestinal mucosa (Niyogi, 2005).  Its symptoms include watery diarrhea with 
mucus, fever, malaise, and abdominal cramping (Niyogi, 2005).  Ulceration of the 
mucosa may also result in bloody mucoid stools and/or fembrile diarrhea (Niyogi, 
2005).  The species and the number of organisms ingested determine the 
severity and range of symptoms expressed by an infected person.  It has been 
shown that persons with conditions such as septicemia, bacteremia, dehydration, 
hypoglycemia, uremic and hemolytic syndrome, and toxic megacolon can lead to 
additional complications if they become infected with Shigella spp. (Phalipon and 
Sansonetti, 2007).   
 Worldwide there are more than 164 million cases of shigellosis every year, 
99% of which are in developing countries 
(www.who.int/vaccine_research/disease/shigella/en/).  More than one million of 
these 164 million cases result in death 
(www.who.int/vaccine_research/disease/shigella/en/).  Children under five are at 




and dehydration, accounting for 61% of all deaths from shigellosis and 69% of 
the total number of Shigella flexneri infections 
(www.who.int/vaccine_research/disease/shigella/en/).  S. flexneri is found most 
commonly in underdeveloped countries while S. sonnei is usually found in 
developed countries (Niyogi, 2005).  S. dysenteriae outbreaks can be found in 
both (Niyogi, 2005).  The fourth species, S. boydii, is rarely found outside the 
Indian subcontinent (Niyogi, 2005). 
 Shigella infections are primarily transmitted though the fecal-oral route 
(DuPont, 1989).  With conditions such as contaminated or uncooked food, water 
supplies contaminated with sewage, poor hygienic practices, and overcrowding 
contribute to epidemics (DuPont, 1989).  Outbreaks that occur in the United 
States and Europe affect certain groups of people more often than others 
(Niyogi, 2005).  Those at higher risk include children in day-care centers, migrant 
workers, travelers to developing countries, workers of custodial institutions and 
homosexual men (Niyogi, 2005).  In the United States S. sonnei is found three 
times more often than S. flexneri but S. flexneri is the species usually found in 
infected homosexual men (Niyogi, 2005).  When associated with human 
immunodeficiency virus (HIV) or acquired immune deficiency syndrome (AIDS), 
S. flexneri can lead to complications including persistent or recurrent intestinal 
disease and bacteremia (Niyogi, 2005).  S. flexneri is commonly associated with 
these infections in developing countries, while epidemic outbreaks are usually 
attributed to S. dysenteriae.  Most fatal cases of shigellosis are the result of 




toxin) (O’Brien et al., 1980).  It is a potent cytotoxin responsible for intestinal 
symptomatology and other major systemic complications, including Hemolytic 
Uremic Sydnrome (HUS) (Phalipon et al., 2008). 
 Shigella flexneri enters a host orally, making its way to the large intestine 
where it invades the colonic epithelium after passing through the upper digestive 
system.  The bacterium easily survives passing through the upper digestive tract 
and small intestine into the colon due to its high acid tolerance (Sur, 2004).  It 
has been shown that Shigella spp. are able to promote their own invasion of the 
colonic epithelium by down regulating certain antimicrobial peptides that are 
released in the gastrointestinal tract, thereby decreasing the host’s innate 
immune response (Islam et al., 2001).  During invasion of the intestinal 
epithelium, Shigella spp. must reach the basolateral side of the epithelial cell 
before they can initiate cell invasion, as they are unable to infect via the apical 
face (Schroeder and Hilbi, 2008).  Once in the large intestine, microfold cells (M 
cells) in the colon ingest S. flexneri in vacuoles via macropinocytosis (Niyogi, 
2005) (Owen, 1986).  It then escapes the vacuole into the cytosol, traveling to 
macrophages associated with M cell-associated lymphoid follicles (Sansonetti et 
al., 1996).  S. flexneri is exposed to the resident macrophage, whose job it is to 
engulf and degrade any incoming material, after being transcytosed into an 
intraepithelial pocket by M cells (Schroeder and Hilbi, 2008).   
 After transcytosis to the intraepithelial pocket and engulfment by 
macrophages, S.flexneri begins initiating apoptosis of those macrophages, via a 




cytokines interleukin-1β (IL-1β) and IL-18 (Schroeder and Hilbi, 2008) 
(Sansonetti, 2000).  IL-1β is responsible for triggering the major inflammation 
shigellosis causes in the lower intestine; however both cytokines activate acute 
and inflammatory responses (Schroeder and Hilbi, 2008) (Sansonetti, 2000).  IL-
18’s role is not fully understood but it is known that it increases the innate 
immune response by activating natural killer cells and promoting gamma 
interferon production (Schroeder and Hilbi, 2008) (Sansonetti, 2000).  The 
inflammation caused by the infection leads to recruitment of IL-8, which then 
recruits polymorphonuclear leukocytes (PMN) that allow more bacteria to bypass 
the M cells to reach the submucosa via destabilization of the epithelial lining 
(Schroeder and Hilbi, 2008) (Sansonetti, 2000).  S. flexneri also alters the protein 
composition of the tight junctions of epithelial cells to loosen them (Schroeder 
and Hilbi, 2008).  This combination of effects initially facilitates the invasion, 
causing the bloody diarrhea S. flexneri is well known for, until the immune system 
takes over and begins killing the bacteria (Schroeder and Hilbi, 2008). 
 After crossing the epithelial barrier of the colon, S. flexneri can then induce 
its own ingestion by the colonic epithelial cells and it can begin using actin based 
motility (ABM) to move through the cytoplasm to promote entry into neighboring 
epithelial cells laterally (Mounier et al., 1992).  This further contributes to the 
inflammatory process.  Ultimately, the symptoms attributed to shigellosis, 
inflammation and ulceration of the mucosa in the colon, however, are the result 
of the response to infection by the host’s immune system (Wassef et al., 1989) 





Invasion via the Basolateral Face 
 After killing subepithelial macrophages, shigellae invade colonic epithelial 
cells from their basolateral face (Sansonetti et al., 1986).  Once inside these 
cells, shigellae must escape from the phagosome into the cytoplasm before they 
can begin replicating and spreading to adjacent colonic epithelial cells 
(Sansonetti et al., 1986).  It was shown that the loss of the 31-kb entry region in 
S. flexneri strains leads to the loss of invasiveness and the ability to escape the 
phagosome.  These functions can be restored by complementation with the 
Sallmonella enteric serovar Typhimurium Sallmonella pathogencity island-1 (SPI-
1) (Paetzold et al., 2007).  Due to the homology of the genes contained in SPI-1 
to the genes on the large virulence plasmid of S. flexneri, complementation is not 
surprising (Paetzold et al., 2007).  One major difference between these two 
bacteria (S. typhimurium and S. flexneri) is that the former can replicate inside 
the phagosome while the latter must escape before it can begin replication 
(Tekouchi, 1967) (Sansonetti et al., 1986).  Complimentation by SPI-1 returns the 
ability to invade and escape the phagosome, even if the 31-kb region is missing 
(Paetzold et al., 2007).  If the entire plasmid is missing, complementation with 
SPI-1 only allows S. flexneri to invade a host cell, but does not restore the ability 
to escape the phagosome (Paetzold et al., 2007).  This suggests that the genes 
required for S. flexneri to escape the phagosome are contained on the virulence 




 To induce cytoskeletal rearrangement and phagocytosis into the host cell, 
additional TTSS effectors are secreted by Shigella spp. after the formation and 
insertion of a “translocon pore” into the host cell’s cytoplasmic membrane 
(Menard et al., 1994) (Watarai et al., 1995) (Menard et al., 1996) (Blocker et al., 
1999).  The pathways by which these interactions occur are not fully understood.  
There are five effector proteins most commonly studied with regard to the 
induction of phagocytosis by the host cell, IpaA, IpgB1, IpgB2, IpaC and IpgD.  
IpaA is able to depolymerize actin, and IpgB1 and IpgB2 are able to induce 
membrane ruffling by mimicking RhoG and RhoA, respectively (Alto et al., 2006) 
(Handa et al., 2007).  IpaC has been proposed to interact with Cdc42 and to 
nucleate actin (Terry et al., 2008) (Tran Van Nhieu et al., 1999).  The last of the 
commonly studied effectors is IpgD which is described as a phosphoinositide 4-
phosphate that has the ability to hydrolyze phosphatidylinositol-4,5-biphosphate 
[PtdIna(4,5)P2], thereby disassociating the cytoskeleton from the plasma 
membrane (Hilbi, 2006) (Niebuhr et al., 2002). 
 After S. flexneri escapes the phagosome, it can begin its lateral spread 
through the colonic epithelium.  While S. flexneri is a non-motile bacterium, it can 
use actin-based motility to move within the cytoplasm of the host cell.  The actin 
polymerization is controlled by IcsA (intracellular spread) which localizes to the 
old pole after cell division (Purdy, 2007).  IcsA (also know as VirG) is able to 
interact with host cell N-WASP and Arp2/Arp3, with the help of IcsP and PhoN2, 
which allows the nucleation of actin and movement throughout the cytoplasm 




works at the opposite pole to depolymerize α-tubulin, allowing the bacterium to 
pass through the host cell’s thick intracellular microtubular network (Yoshida et 
al., 2006). 
 The goal of Shigella flexneri is to enter a cell, replicate, then enter another 
cell, replicate, and so on, continuing its lateral spread throughout the colonic 
epithelium.  S. flexneri needs to reach the host cell cytoplasm to replicate and to 
protect itself from the extracellular immune system components (Schroeder and 
Hilbi, 2008).  The replicative niche of S. flexneri is the cytoplasm of epithelial cells 
(Schroeder and Hilbi, 2008).  Once it escapes the vacuole into the cytoplasm it 
must protect itself from intracellular defense autophagy using IcsB to mask IcsA, 
which contains an autophagy-inducing recognition site (Schroeder and Hilbi, 
2008).  Using actin based motility, S. flexneri moves to the tight junctions 
between the host epithelial cells where it can be taken up by the adjoining 
epithelial cell where it resides inside of a double-membrane vacuole (Schroeder 
and Hilbi, 2008).  It then escapes into the new cell’s cytoplasm by lysing the 
vacuole using the TTSS to secrete various effectors.  It then begins the process 
of replication and further lateral spread through the colonic epithelium (Figures 
1.1 and 1.2). 
 
Pathogenic Shigellae 
 Shigella spp. belong to the family Enterobacteriaceae and are closely 











Figure 1.1 Schematic of Shigella flexneri Infection 
Shigella flexneri is ingested by the M cells of the colon, exposed to the resident 
macrophages inducing their apoptosis, then moves through the cell to the basal 
face.  It then uses the TTSS to induce its own uptake into the cell where it can 
escape the vacuole into the cytoplasm.  Once in the cytoplasm it can replicate 














Figure 1.2 Intracellular Movement of Shigella flexneri 
Shigella flexneri utilizes IcsA to form an actin tail allowing it to move throughout 
the cytoplasm and VirA to degrade microtubules allowing the bacteria to 








are gram-negative gastrointestinal pathogens that cause disease in humans and 
higher primates, as do the other pathogens in its family including Salmonella, 
Yersina, and Escherichia (DuPont et al., 1989).  Similar to its family members, 
these bacteria are facultatively anaerobic, oxidase negative, and they have the 
ability to reduce nitrate and ferment glucose (Kreig and Holt, 1984).  Testing for 
ornithine decarboxylation and manitol and xylose fermentation allows for 
biochemical differentiation between the species (Kreig and Holt, 1984).  Also, the 
species can be differentiated serologically based on the species-specific O-
antigen components that each contains (Kreig and Holt, 1984).  There are four 
serotypes A, B, C and D belonging to the four species S. dysenteriae, S. flexneri, 
S. boydii and S. sonnei, respectively (Niyogi, 2005).   
 Shigella spp. require very few organisms, approximately 10-100, to elicit 
the disease shigellosis, making it extremely infectious and easily spread (DuPont 
et al., 1989).  Poor sanitation and contaminated food or water sources are 
usually the cause of outbreaks of shigellosis.  Infected people who display the 
symptom of diarrhea are most responsible for transmission of the disease 
(Niyogi, 2005).  Shigellosis is usually self-limiting with symptoms lasting five to 
seven days and it can be treated orally with antibiotics (Hueck, 1998).  However, 
infected patients can spread the disease as long as they are excreting the 
organism which can last up to four weeks (Sur, 2004).  This length of time can be 
reduced if properly treated with antibiotics (Sur, 2004). 
 Today, treatment consists mainly of oral antibiotics, including quinolones, 




effective antibiotics available for use is constantly decreasing due to the 
emergence of new antibiotic resistant strains (Niyogi, 2005).  Worldwide, strains 
of shigellae have emerged that are resistant to many antibiotics including 
tetracycline, sulfonamides, ampicillin and trimethoprim-sulfamethoxazole (Hueck, 
1998).  To avoid dehydration, an infected person should consume electrolyte 
drinks to replace fluids and restore nutrients lost from diarrhea during treatment 
for shigellosis along with proper antibiotic treatment for the disease 
(http://www.nlm.nih.gov/medlineplus/ency/article/000295.htm). 
 
Genetics of Virulence  
 All Shigella spp. contain a large virulence plasmid.  The genes it encodes, 
along with the genes encoded on the pathogenicity islands located in its 
chromosome, are the basis for shigellae virulence (Schroeder and Hilbi, 2008).  
Virulence factors including antibiotic resistance, iron acquisition and proteases 
can be found encoded on the pathogenicity islands (Schroeder and Hilbi, 2008).  
All the genes for cellular invasion are contained on the large virulence plasmid, 
the most important aspect of shigellae virulence.  This large plasmid is about 
200-kb with approximately 100 genes, but it can vary in size among the four 
species (Maurelli et al., 1985) (Yoshikawa et al., 1988).  The virulence plasmid 
contains genes necessary for the uptake by epithelial cells and dissemination of 
the bacteria throughout the colonic epithelium (Wantanabe, 1990).  The entry 
region of the virulence plasmid, 31-kb in size, encodes a type III secretion system 




contains other genes that encode proteins used after invasion of a host cell 
(Sansonetti, 1982) (Yoshikawa et al., 1988).  Contained in the 31-kb entry region 
are the mxi-spa operon and ipa-ipg operon which are responsible for encoding 
the type III secretion apparatus (TTSA) and the type III secreted protein 
effectors/translocators IpaA, IpaB, IpaC, IpaD and the molecular chaperone IpgC 
(Espina et al., 2006).  Research has shown that if shigellae lose this large 
plasmid they cannot infect and cause disease (Yoshikawa et al., 1988).   It has 
also been shown that non-pathogenic lab strains of E. coli can become invasive 
after receiving the Shigella virulence plasmid (Sansonetti, 1982). 
 The genes in the entry region can be differentiated into four categories 
based upon their specific functions (Schroeder and Hilbi, 2008).  Proteins 
secreted by the TTSA comprise the first category.  They are mainly the ipa 
(invasion plasmid antigen) genes, whose functions are generally considered to 
be as effector and/or translocator proteins that are directly involved in the 
induction of cytoskeletal rearrangement, cell membrane ruffling and pathogen 
uptake (macropinocytosis) (Espina et al., 2007) (Schroeder and Hilbi, 2008).  The 
second group is composed of the TTSA structural genes.  They are the mxi 
(membrane expression of ipa proteins) and spa (surface presentation of ipa 
antigens) genes (Espina et al., 2007) (Schroeder and Hilbi, 2008).  The TTSS 
apparatus consists of a basal body and needle that are composed of various 
polymers of the Mxi and Spa structural proteins (Espina et al., 2007).  Expression 
of the early and late entry region genes are controlled by different transcriptional 




components (Schroeder and Hilbi, 2008).  The last group consists of the 
molecular chaperones, whose function is to maintain effector and translocator 
proteins while they are stored in the bacterial cytoplasm prior to secretion 
(Schroeder and Hilbi, 2008). 
 
Bacterial Secretion Systems 
 All bacteria possess secretion systems as part of their normal function.  In 
addition many gram-negative bacterial pathogens use dedicated secretion 
systems to transport effector molecules or virulence factors into their 
environment or into targeted host cells as a key part of their virulence.  Currently, 
there are six named bacterial secretion systems which have been classified 
based on the numbering system I, II, III, IV, V and VI.  Two of the systems are 
sec-dependent (secretory), types II and V, while types I, III and IV are classified 
as being sec-independent (Russel, 1998) (Harper and Silhavy, 2001).  The two 
sec-dependent secretion systems make use of the machinery of the general 
secretory pathway to translocate proteins across the inner membrane of bacteria 
(Russel, 1998) (Harper and Silhavy, 2001).  They do this by catalyzing and 
translocating the proteins across the bacterium’s inner membrane to its 
periplasmic space via as N-terminal signal peptide that is removed in the process 
(Russel, 1998) (Harper and Silhavy, 2001).  The type VI secretion systems are 
relatively new, being discovered in 2006 in Vibrio cholerae by Stefan Pukatzki et 
al (Pukatzki et al., 2006).  It has since been found in several gram-negative 




however, this system is not yet very well characterized (Aubert et al., 2008) 
(Zheng and Lewis, 2007) (Pukatzki et al., 2006).  It is thought to be sec-
independent due to the absence of an N-terminal signal sequence on the 
proteins that are secreted (Pukatzki et al., 2006). 
 Type I secretion systems are the simplest of the six, containing only three 
proteins an ABC protein or ATP binding cassette protein, a membrane fusion 
protein and an outer membrane trimeric protein.  Type I secretion systems 
transport proteins in a single step through a continuous channel from the inner 
membrane, through the periplasm, to the outer membrane (Holland et al., 2005).  
Type II secretion systems utilize the sec pathway to transport proteins to the 
periplasm where it then uses a complex of 12-14 protein components to transport 
the proteins from the periplasm to the environment surrounding the cell (Russel, 
1998).  The type III secretion system (already described in part) is made up of a 
basal body that spans the inner and outer membranes and an extracellular 
needle complex which allows the bacteria to directly inject effectors directly into a 
target cell’s cytoplasm.  Type III secretion is an ATPase-driven system and it has 
been termed contact dependent secretion since contact with a host cell is the 
typical signal needed to induce this secretion (Hueck, 1998).  Type IV secretion 
systems were originally thought to be limited to conjugal transfer systems that 
transport bacterial DNA between bacteria to facilitate natural genetic exchange 
(Winans et al., 1996).   It has since been determined that this pilus-like transport 
system can also export monomeric and multisubunit proteins, as well as bacterial 




secretion systems: 1) conjugation systems; 2) effector translocator systems; and 
3) DNA release/uptake systems (Alvarez-Martinez and Christie, 2009).  The first 
two of which usually require direct contact with a target cell for activation 
(Alvarez-Martinez and Christie, 2009).  Type V secretion systems are known as 
autotransporters or two-partner secretion systems (Jacob-Dubuisson et al., 2004) 
They utilize the sec pathway for the first step in their function (Jacob-Dubuisson 
et al., 2004).  Type V secretion systems export large proteins possessing an N-
terminal sec-dependent signal domain, the mature portion of the protein, and a 
C-terminal translocation unit that contains three regions, α-, β- and γ- (Jacob-
Dubuisson et al., 2004) (Klauser et al., 1993).  The sec signal domain allows the 
protein to move through the inner membrane and into the periplasm via the 
standard sec pathway machinery (Jacob-Dubuisson et al., 2004) (Klauser et al., 
1993).  The β-region then inserts itself into the bacterium’s outer membrane 
where it forms a pore that has characteristic β-barrel structure (Klauser et al., 
1993).  This pore allows the passage of the remaining regions (often referred to 
as the “cargo” regions) through the outer membrane where they can be cleaved 
by autoproteolysis and released into the extracellular environment (Klauser et al., 
1993).  In some cases the cargo remains attached as a bacterial surface protein 
(Klauser et al., 1993).  The type V system is not as versatile as the other 
secretion systems, such as the type II or type III systems, due to its ability to only 
secrete one molecule of the natural extracellular protein substrate (Jacob-
Dubuisson et al., 2004).  Type VI secretion systems are the least characterized 




been found in several gram-negative bacteria in addition to the ones previously 
listed (Aubert et al., 2008) (Zheng and Leung, 2007) (Pukatzki et al., 2006). 
 
The Type III Secretion System 
 In order to invade the epithelial cells of the human colon, Shigella spp. 
utilize the TTSS and a set of secreted translocator and effector proteins for 
targeting, penetrating and generally manipulating a host cell.  The TTSA is able 
to directly inject effector proteins into a host cell’s cytoplasm, thereby acting as a 
molecular syringe.  After injection of effectors, cytoskeletal rearrangements and 
ultimately uptake of the bacterium are mediated by the interaction of the effector 
proteins and their target signaling molecules within the host cell (Cornelis, 2006). 
 The TTSA is composed of a basal body that spans the inner and outer 
membrane of the bacterium, and an extracellular needle protruding from the 
bacterium’s outer membrane into the surrounding environment (Schroeder and 
Hilbi, 2008).  The basal body structure is composed of seven rings, while the 
needle is a MxiH polymer approximately 50 nm long, 7 nm wide with an inner 
channel that has a diameter of about 2.5 nm (Epler et al., 2009).  On the 
cytoplasmic face of the bacterium, the TTSA possesses an ATPase that has 
been shown to be involved in protein unfolding, chaperone release and 







The Ipa Proteins 
 To gain entry into a target cell and take control of the cytoskeletal proteins 
needed to promote bacterial uptake, Shigella utilizes several secreted effector 
proteins.  At the tip of the MxiH polymer needle is IpaD, which is believed to 
participate in sensing environmental signals and initiating the process of 
secretion induction (Espina et al., 2006).  IpaD is also a major secretion substrate 
in Shigella type III secretion.  IpaD sensing of bile salts in the intestine leads to 
IpaB secretion and recruitment to the TTSA needle tip (Stensrud et al., 2008).  At 
this point, the Shigella TTSS is prepared for full induction of type III secretion.  
After subsequent contact with a host cell, the Shigella TTSS then begins the 
secretion of other effectors that include the final translocator protein IpaC and 
additional effectors that are secreted into the host cell cytoplasm (Epler et al., 
2009) (van der Goot et al., 2004).  Several labs have shown that conditions 
mimicking host cell contact can induce secretion by the TTSA.  The addition of 
small amphipathic dyes, such as Congo red, brilliant orange or Evens blue, 
appear to mimic host cell contact to induce Shigella type III secretion (Parsot et 
al., 1995) (Bahrani et al., 1997).   
 Espina et al. demonstrated that IpaD localizes to the tip and caps the 
MxiH polymer needle of the TTSA (Espina et al., 2006).  The inability of IpaD null 
mutants to invade and their hypersecretion of TTSS effectors into the 
extracellular environment during overnight cultures demonstrate IpaD serves as 
a crucial component of the Shigella TTSS, perhaps as a regulatory component 








Figure 1.3 The Type III Secretion System (TTSS) of Shigella flexneri 
The TTSS of S. flexneri with the membrane spanning basal body and 
extracellular needle protruding from the surface.  This shows the TTSS in contact 
with a host cell and the tip complex assembled along with the translocon inserted 






done by our group has shown that secretion of IpaB can be induced by the 
presence of bile salts, specifically deoxycholate, which leads to IpaB colocalizing 
with IpaD at the distal tip of the needle (Olive et al., 2007).  IpaB possesses a 
cholesterol binding function that may serve as a priming step that allows the 
needle to recognize bacterial interaction with the host cell (Hayward et al., 2005). 
 Within the cytoplasm of S. flexneri, the molecular chaperone IpgC 
(invasion plasmid gene) binds to IpaB before it is secreted (Birket et al., 2007).  
IpgC prevents the aggregation of IpaB in the bacterial cytoplasm and its 
association with the other translocator protein IpaC (Menard et al., 1994) (Page 
et al., 1999) (Lunelli et al., 2009).  IpaB binding to IpgC is also thought to stabilize 
IpaB in a pre-secretion state prior to its passage through the TTSA needle 
(Menard et al., 1994) (Page et al., 1999).  It was shown by circular dichroism 
(CD) spectroscopy that IpgC has a significant α-helical secondary structure (data 
not shown).  This has been confirmed by the solving of IpgC’s crystal structure 
(Lunelli et al., 2009).  IpaB and IpaC are less ordered (based on CD analysis), 
but the binding of IpgC to IpaC induces significant secondary structural change, 
increasing the amount of α-helical structure, and stabilization (Birket et al., 2007).  
IpgC is believed to have a similar effect on IpaB, but the details of this, such as 
the specific residues or regions involved, have not been determined (Birket et al., 
2007). 
 IpaB is important to study because it has several functions that are key to 
Shigella pathogenesis.  As a secreted effector protein, as a regulator of type III 




pore that forms in the host cell membrane (Schroeder and Hilbi, 2008).  To 
escape the macrophage after initially crossing M cells, S. flexneri secretes IpaB 
to induce apoptosis via a caspase1-dependent pathway (Hilbi, 1998).  This 
apoptotic (pyroptotic) pathway results in the massive release of IL-1β, which 
provides the signal for induction of the inflammatory process that give rise to the 
symptoms of shigellosis (Sansonetti, 2000).  IpaB also serves to control effector 
regulation, as does IpaD (Menard et al., 1994).  IpaB null mutants show the same 
overall phenotype as do ipaD null mutants, including non-invasiveness and 
hypersecretion of effectors into the extracellular supernatant of overnight cultures 
(Menard et al., 1994).  IpaB is also one component of the two-part translocon 
pore that becomes inserted into the host cell’s cytoplasmic membrane shortly 
after host cell contact.  The other translocon component is IpaC (Schroeder and 
Hilbi, 2008).  IpaD allows this pore to remain in contact with the TTSA needle tip 
(Schroeder and Hilbi, 2008).  This pore allows formation of a channel through the 
membrane to the host cell’s cytoplasm, thereby allowing direct injection and 
secretion of later effectors directly from the bacterial cytoplasm to the host cell’s 
cytoplasm (Menard et al., 1994) (Zychlinsky et al., 1994) (Blocker et al., 1999). 
 Along with IpaB, the IpgC chaperone binds to the second 
translocator/effector protein, IpaC, keeping it stable in the cytoplasm until it joins 
IpaB as a translocon pore component (Menard et al., 1994) (Page et al., 1999).  
Along with forming the translocon pore, IpaC is also involved in signaling to the 
host cell.  Cdc42 is a small Rho-family GTPase that IpaC has been proposed to 




1999).  Little is known about this interaction, but it has been shown that IpaC can 
nucleate actin (Kueltzo et al., 2003).  Recent findings suggest that the ability for 
IpaC to nucleate actin is much more important than its ability to interact with 
Cdc42 (Terry et al., 2008). 
 
The Molecular Chaperone IpgC 
 Invasion plasmid gene C (IpgC) is the molecular chaperone for IpaB and 
IpaC, both of which are translocator proteins for the Shigella TTSS (Parsot et al., 
2003) (Birket et al., 2007).  There are three classes of molecular chaperones 
used by the TTSS (Parsot et al., 2003) (Birket et al., 2007).  Class I chaperones 
are associated with late effector proteins that are targeted for direct injection into 
the target cell’s cytoplasm (Parsot et al., 2003).  These can be divided into two 
subclasses, IA and IB, depending on whether they bind with one protein, IA, or 
more than one protein, IB (Parsot et al., 2003) (Birket et al., 2007).  The class II 
chaperones associate with the translocator proteins for its cognate TTSS (Parsot 
et al., 2003) (Birket et al., 2007).  The class III chaperones bind with proteins of 
the flagellar TTSS and these are not relevant in Shigella (Parsot et al., 2003) 
(Birket et al., 2007).  Several defining characteristics are common of most TTSS 
chaperones.  They are their small molecular masses and low pIs (Parsot et al., 
2003) (Birket et al., 2007).  Some chaperones are also responsible for regulating 
late gene expression by interacting with transcription factors after initial contact 
with the host cell (Parsot et al., 2004).  IpgC is a class II molecular chaperone 




Shigella flexneri (Birket et al., 2007).  IpgC is responsible for complexing with and 
stabilizing the translocators IpaB and IpaC within the bacterial cytoplasm, thus 
preventing their interaction and/or degradation until type III secretion is activated 
(Birket et al., 2007).  IpgC is a small (20 kDa) protein with a very acidic pI of 4.6, 
which is responsible for several roles including acting as a chaperone and acting 
as a  transcription activator within the Shigella TTSS after association with MxiE 
(Cornelis and Van Gijsegem, 2000) (Page et al., 2001) (Birket et al., 2007). 
 IpgC serves as a transcriptional co-activator of virA and ipaH9.8 (Pilonieta 
and Munson, 2008).  Pilonieta and Munson showed that production of VirA and 
IpaH9.8 can be increased when IpgC and MxiE associate which was determined 
trough co-purification experiments (Pilonieta and Munson, 2008).  While originally 
thought to be a transient interaction, Pilonieta and Munson showed that the 
increased transcription of virA and ipaH9.8 is only seen after the release of IpgC 
from both IpaB and IpaC (Pilonieta and Munson, 2008). 
 IpgC’s interaction with IpaB and IpaC is of interest due to its ability to bind 
multiple partners having little or no sequence similarity (Birket et al., 2007).  
IpgC’s effect on IpaC has been investigated by other members of the lab to 
better understand IpaC’s function as a Shigella virulence determinant and IpaC’s 
role in this process.  IpaC is a 42 kDa protein with functions that include the 
ability to disrupt liposomes, interact with actin, and to promote invasion of 
epithelial cells (Picking et al., 2001) (Kueltzo et al., 2003).  It has been shown 




the latter protein while simultaneously stabilizing IpaC’s secondary structure 
(Birket et al., 2007).  No such data are available for the IpgC/IpaB interaction. 
 
Research Focus 
 The research presented here is intended to further our understanding of 
the structure and topography of IpaB, in the presence and absence of binding to 
its chaperone IpgC.  Structural information of IpaB is limited due to its large size, 
(62 kDa) and hydrophobicity, however, several key regions of IpaB have been 
determined based on the predicted secondary structure analysis and structure-
function analyses from mutagenesis studies (Birket et al., 2007).  This study is 
intended to further past structure analyses and to better understand and 
characterize key regions within IpaB and its structure by generating the first 
biophysical and structural data available for this protein.  I hypothesize that IpaB 
is a highly structured protein, with and without its IpgC chaperone, and is more 
thermally stable when bound to IpgC which will be tested using a variety of 
spectroscopic analyses.  These findings will be extended using tryptophan 
scanning mutagenesis to help determine the topology of IpaB, which will perhaps 
allow identification of regions involved in IpaB’s interaction with IpgC. 
 Within the cytoplasm of Shigella flexneri, IpaB is complexed with IpgC until 
it disassociates to become loaded into the needle for export to the TTSA neddle 
tip.  This is why it is important to study the influence IpgC’s binding has on IpaB’s 
structure.  IpaB has two key roles, inducing apoptosis in the macrophage after 




into the host cell membrane, both of which are vital steps of S. flexneri infection.  
If IpaB is not secreted, S. flexneri cannot induce apoptosis to escape the 
macrophage.  Without the IpaBC translocon pore, S. flexneri becomes 
noninvasive and it is incapable of causing disease in a host.  Others have studied 
and characterized the IpaBC translocon pore interactions along with IpaC and 
IpgC interactions (Birket et al., 2007).  Some of the same biophysical and 
molecular methods utilized in those studies have been applied in this study to 
better characterize the structure of IpaB, its interactions with IpgC and the 
conformational changes when associated with other protein partners.  I will 
combine tryptophan scanning mutagenesis with Trp fluorescence analysis, 
thermal unfolding scans and Förster resonance energy transfer from Trp to a 








MATERIALS AND METHODS 
Reagents and Buffers 
 
Coomassie Blue Protein Gel Stain 
250 ml methanol 
1.25 g Coomassie brilliant blue 
75 ml acetic acid 
175 ml diH2O 
 
8X His-Tag Binding Buffer 
2.72 g imidazole 
237 g NaCl 
19.36 g Tris 
Adjust to 1.00 L with diH20 
 
4X His-Tag Charge Buffer 
52.56 g NiSO4 
Adjust to 500 ml with diH2O 
 
4X His-Tag Elution Buffer 
136 g imidazole 
58.44 g NaCl 
4.84 g Tris 
Adjust to 500 ml with diH2O 
pH to 7.9 
 
4X His-Tag Strip Buffer 
74.4 g EDTA 
58.44 g NaCl 
4.84 g Tris 
Adjust volume to 500 ml with diH2O 





8X His-Tag Wash Buffer 
5.44 g imidazole 
117 g NaCl 
9.68 g Tris 
Adjust volume to 500 ml with diH20 
pH to 7.9 
 
Luria-Bertani Broth (LB) 
25.0 g LB broth 
1.00 L diH2O 
 
Luria-Bertani Agar (LB) 
40.0 g LB agar 
1.00 L diH20 
 
10X Phosphate Buffered Saline (PBS) 
85.0 g NaCl 
10.7 g sodium phosphate, dibasic 
3.90 g sodium phosphate, monobasic 
1.00 L diH2O 
 
10% SDS-PAGE Separating Gel 
4.00 ml diH20 
2.50 ml 1.5 M Tris-HCL, pH 8.8 
100 μl 10% SDS 
3.33 ml 30% Bis:Acrylamide 
 
12% SDS-PAGE Separating Gel 
3.00 ml diH20 
2.50 ml 1.5 M Tris-HCL, pH 8.8 
100 μl 10% SDS 
4.00 ml 30% Bis:Acrylamide 
 
15% SDS-PAGE Separating Gel 
2.50 ml diH20 
2.50 ml 1.5 M Tris-HCL, pH 8.8 
100 μl 10% SDS 
5.00 ml 30% Bis:Acrylamide 
 
5% SDS-PAGE Stacking Gel (2) 
2.85 ml diH2O 
1.25 ml 0.5 M Tris-HCl, pH 6.8 
50.0 μl 10% SDS 






SDS-PAGE Running Buffer 
2.42 g Tris 
14.41 g glycine 
10.0 ml SDS 
1.00 L diH2O 
 
1X Sodium Phosphate Dialysis Buffer (NaP buffer) 
20 ml .5 M NaP 
8.77g NaCl 
5 mL OPOE 




IpaB Tryptophan Mutant Construction 
 All tryptophan mutations in ipaB were generated using inverse PCR with 
pHS2-IpaB, encoding IpaB, as the template.  Primers were made to possess 
GAGAGA, a restriction site flanking the codon to be mutated and approximately 
18 nucleotides beyond the mutation site.  Primers for Trp mutagenesis are listed 
in Table 2.1.  Inverse PCR produced a linear fragment which was subsequently 
digested with the appropriate restriction endonucleases and intromolecularly 
ligated.  GAGAGA sequences are present at the ends of the fragment to increase 
the efficiency of restriction digestion.  Ligation products were transformed into 
Nova Blue E. coil.  Resulting plasmids were purified using the QIAGEN 
QIAquickTM plasmid purification kit.  Purified plasmids were electroporated into 
the ipaB null Shigella flexneri strain SF620 and placed onto trypticase soy agar 


















         TATTT 
F275W B96f-GAGAGAGAGCTTAAGAATGATCTGGCTCTATGGCAGTCTCTC 




         TCTC 
F382W B100f-GAGAGAGAGCTCGAGGGCTTGGGCGTCGATC 
B101r-GAGAGAGAGCTCGAGCATTTTTGTCCATGCATCTGAAAGG 





           AACAC 
F514W B106f-GAGAGAGAGGCTAGCGACAAATCTAGCAGACCT 
B107r-GAGAGAGAGGCTAGCGCTGTTCTGCCAAACAGCAGAAGCGA 
           CACT 
I553W B108f-GAGAGAGAGAGATCTATTAGCCTCAATGT 
B109r-GAGAGAGAGAGATCTGCCCATACTTCCTGCAATTGGC 
Table 2.1 Table of Primers 









colonies were chosen for further assays as these contained both the 
electroporated plasmid and the virulence plasmid based on Congo red selection.  
Congo red (CR) selection is based on the fact that Shigella lacking the virulence 
plasmid appear as large white colonies on CR-containing TSA plates.  Virulence 
plasmid containing bacteria appear as smaller, red colonies.  W105F (ΔW) was 
constructed to remove the natural tryptophan residue in IpaB.  This was used as 
a template for subsequent mutants, in which a Trp was introduced at novel sites. 
 
Construction/Production of Recombinant Proteins 
 Mutated ipaB was subcloned from pHS2 into pET15b.  The resulting 
mutant IpaB/pET15b constructs were then transformed into Nova Blue E. coli.  
Transformants were screened with T7 promoter and terminator primers.  Positive 
plasmids were then purified using a QIAGEN QIAquickTM plasmid purification kit 
and then co-transformed with IpgC/pACYC into Tuner (DE3) E. coli.  To select for 
bacteria containing both plasmids, transformations were plated on LB plates 
containing ampicillin and chloramphenicol.  Several colonies were selected and 
frozen as permanent stocks.  A loop of the permanent stock was resuspended in 
50 ml of LB and grown overnight.  The 50 ml culture was then divided evenly 
between 4 L of LB, each containing 100 μg/ml ampicillin and 25 μg/ml 
chloramphenicol. Cultures were grown to mid-log phase (OD600 = 0.6) and the 
protein expression was induced using 0.5 M isopropyl-thio-2-D-
galactopyranoside (IPTG).  Induced cultures were grown for an additional three 




ml/L of culture, with 1X His-tag binding buffer.  The bacterial suspension was 
frozen at –20°C. 
 
Gentamycin Protection Invasion Assay 
 Henle 407 cells were seeded on a 24 well tissue culture plate and 
incubated with minimal essential medium (MEM) with Earle’s salts and 
supplemented with 10% bovine serum in CO2 at 37°C until semi-confluent.  S. 
flexneri strains were grown at 37°C with shaking in 10 ml of TSB to mid-log 
phase (OD600 = 0.6).  One μl of the bacterial culture was added to Henle cells in 
MEM-glucose and centrifuged at 1,000 x g for five minutes to force contact.  The 
plates were incubated for 30 minutes at 37°C in a CO2 incubator.  The cells were 
then washed with MEM-gentamycin (50 grams/L) with 5% bovine serum and 
incubated at 37°C in a CO2 incubator for one hour in MEM-gentamycin to kill any 
extracellular S. flexneri.  After incubation, the MEM-gentamycin was removed by 
aspiration, cells were washed once with MEM-glucose no serum, and overlaid 
with melted agarose in deionized water.  They were then overlaid with melted 2X 
LB agar.  Once the agar solidified, cells were incubated at 37°C overnight.  
Colonies were then counted and invasion was calculated relative to 
complimented S. flexneri strains. 
 
Contact-Mediated Hemolysis 
 S. flexneri strains were grown to mid-log phase at 37°C with shaking in 10 




resuspended in 200 μl of 1X PBS.  Sheep erythrocytes were washed at room 
temperature with 1X PBS and resuspended in 1X PBS to the original cell 
concentration.  Fifty μl of red blood cells (RBCs) were aliquoted into a 96 well 
microtiter plate to which 50 μl of the bacterial cell suspension was added per 
well.  Contact was induced by centrifugation at 2500 x g at 22°C for 10 minutes.  
Microtiter plates were then incubated at 37°C for 1 hour.  After incubation, 
RBC/bacterial pellets were vigorously resuspended in ice cold 1X PBS and 
centrifuged at 2,500 x g for 15 minutes at 4°C.  Supernatants were transferred to 
clean, empty wells.  Hemoglobin release was measured by monitoring 
absorbance at 545 nm on a μQuantTM microtiter plate reader. 
 
Ni+ Affinity Protein Purification of His-Tag Containing Proteins 
 Frozen bacterial suspensions were thawed, sonicated and clarified by 
centrifugation for 15 minutes at 10,000 x g.  Three ml of resin were washed with 
five column volumes (CV) of distilled water.  The resin was charged with three 
CV of 1X His-tag charge buffer and then five CV of 1X His-tag binding buffer.   
Clarified supernatants were applied to the column, which was washed with an 
additional five CV of binding buffer.  Non-specifically bound proteins were 
removed with five CV of 1X His-tag wash buffer and bound proteins were then 
eluted in three CV of 1X His-tag elution buffer.  Fractions were collected and 
analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-
PAGE) gel to check for protein production.  The resin was stripped with three CV 





Ni+ Affinity Protein Purification of His-Tag Containing Proteins with OPOE 
 Frozen bacterial suspensions were thawed, sonicated and clarified by 
centrifugation for 15 minutes at 10,000 x g.  Three ml of resin were washed with 
five CV of distilled water.  The resin was charged with three CV of 1X His-tag 
charge buffer and then five CV of 1X His-tag binding buffer.  Clarified 
supernatants were applied to the column; three ml of binding buffer plus 1% n-
octyl-poly-oxyethlene (OPOE) was added.  The column was allowed to rock 
overnight in a cold room at 4°C.  Non-specifically bound proteins were removed 
with five CV of 1X His-tag wash buffer with 1% OPOE and bound proteins were 
then eluted in three CV of 1X His-tag elution buffer with 1% OPOE.  Fractions 
were collected and analyzed by SDS-PAGE gel to check for protein production.  
The resin was stripped with three CV of 1X His-tag strip buffer and stored at 4°C 
for future use. 
 
Dialysis of IpaB/IpgC Proteins Following Purification 
 Proteins were placed in dialysis tubing.  All dialysis steps conducted at 
4°C.  IpaB/IpgC dialyzed in five steps.   
1. Against 1X wash buffer for 1 hour. 
2. Against 1X binding buffer for 2 hours. 
3. Against 500mM NaCl PBS overnight. 
4. Against 300mM NaCl PBS for 1 hour. 




Purified protein was then removed from dialysis tubing, placed into a 1.5 ml 
eppendorf tube and stored at 4°C for up to two weeks. 
 
Dialysis of IpaB Following Purification 
 Proteins were placed in a Thermo Scientific Slide-A-Lyzer dialysis 
cassette, 3 ml to 12ml volume, with a syringe and 21 gauge needle.  All dialysis 
steps were done at 4°C.  Cassettes were dialyzed against 500 ml of NaP dialysis 
buffer for 30 minutes, then 500 ml of fresh NaP dialysis buffer overnight.  The 
protein was then removed from the cassette and the concentration was 
determined by A280 UV absorbance using the equation  
C (concentration) = (absorbance) / (extinction coefficient) 
with an extinction coefficient=11,460 for IpaB. 
 
Determining the Tryptophan Fluorescence Emission Maximium 
 Fluorescence data were collected using a Fluoromax-4 
Spectrofluorometer scanning fluorescence spectrophotometer.  The machine 
was adjusted with a blank that consisted of 0.6 ml PBS.  Tryptophan (Trp) 
fluorescence emission was scanned at wavelengths from 305 nm to 400 nm 
using an excitation wavelength of 295 nm, which allowed for monitoring of 
changes in tryptophan emission between IpaB/IpgC and IpaB alone, as well as 
allowing the comparison of the environments surrounding each Trp for all the 
mutants and the wildtype.  Other settings included a tolerance of 1°C, an 




were taken for each sample with the resulting graph representing an average of 
the three scans. 
Tryptophan Thermal Unfolding Curves 
 Thermal unfolding data were collected using a Fluoromax-4 
Spectrofluorometer scanning fluorescence spectrophotometer.  The machine 
was adjusted with a blank that consisted of 0.6 ml PBS.  For all the proteins, 
fluorescence emission was scanned at wavelengths from 305 nm to 400 nm 
using an excitation wavelength of 295 nm, which allowed for monitoring changes 
in tryptophan emission between IpaB/IpgC and IpaB alone, as well as allowing 
the comparison of the environments surrounding each Trp for all the mutants and 
the wildtype.  Other settings included an equilibration time of three minutes and a 
temperature range from 10°C to 90°C increasing at increments of 2.5°C, with a 
tolerance of 1°C from 10°C to 57.5°C and 1.5°C from 60°C to 90°C. 
 
IAEDANS Labeling of IpaB 
 Protein concentrations were determined by A280 UV absorbance using the 
equation C (concentration) = (absorbance)/(extinction coefficient), with an 
extinction coefficient=11,460 and MW of 62,000 Da for IpaB.  β-mercaptoethonal 
(BME) was added to the purified protein to a concentration of 25 μM and the 
sample was allowed to sit on ice for one hour.  To remove the BME, the proteins 
were placed in Slide-A-Lyzer cassettes, 3 ml to 12 ml volume, and dialyzed 
against four rounds of 500 ml of NaP buffer for 30 minutes each at 4°C.  The 




oxoethyl)amino] ethylamino]-1-naphthalenesulfonic acid (IAEDANS).  
Approximately 1 mg of IAEDANS was mixed with 125 μl of dimethyl sulfoxide 
(DMSO) and this was added to the protein, which was allowed to sit for one hour 
on ice.  Protein samples were again purified using the Ni+ affinity 
chromatography with OPOE as previously described.  Fractions were collected 
and SDS-PAGE was used to determine the fractions that contained protein. 
These fractions were pooled and dialyzed against the NaP buffer using four 
rounds of 500ml for 30 minutes each at 4°C in Slide-A-Lyzer cassettes.  Samples 
were then removed form the cassettes and used for scanning in Förster 
resonance energy transfer studies. 
 
Förster Resonance Energy Transfer (FRET) with AEDANS-Labeled IpaB 
 FRET data were collected using the Fluoromax-4 Spectrofluorometer 
scanning fluorescence spectrophotometer.  The machine baseline was set with 
0.6 ml of PBS.  Samples were excited at a wavelength of 290 nm and scanning 
emission wavelengths were collected from 300 nm to 500 nm, with 1°C 
tolerance, three minute equilibration times and a starting temperature of 20°C.  
Samples were scanned separately using the same concentration of unlabeled 
(donor only) and labeled (donor/acceptor) protein.  Graphs shown here are 
average of each after three scans.  The emission maximum intensity of the 
unlabeled protein relative to the intensity of the labeled protein at the same 
wavelength was compared.  The difference between the emission maximum of 




(Cys309+AEDANS) sample at the donor max wavelength allows the amount of 
energy transfer to be calculated. 
 For each mutant and the native strain, the energy transfer efficiency was 
calculated according to the equation:  
E = (1-(Fda/Fd)) 
where Fda = donor/acceptor intensity and Fd = donor intensity.  After determining 
the amount of energy transferred, the distance between the tryptophan and the 
molecule of AEDANS on Cys309 was calculated using the formula:  
E = (Ro6)/(Ro6+R6) 
where R is the calculated distance separating the donor and acceptor 
fluorophores.  The published Ro value for this donor-acceptor fluorophore pair is 
22Å, which is the theoretical distance that would give 50% energy transfer 
efficiency (Ro) for this specific FRET pair (Lakowicz, 2006).  When determining 
the Ro value, it was assumed the orientation of donor and acceptor dipoles are 








TRYPTOPHAN SCANNING MUTAGENESIS OF IpaB 
Introduction 
 
 Shigella flexneri uses its type III secretion system (TTSS) to facilitate its 
own uptake in the colonic epithelial cells of the large intestine (Sansonetti et al., 
1982b).  Once the S. flexneri TTSS is activated by contact with a host cell (or 
conditions mimicking host cell contact) it begins to transport effector proteins 
through its extracellular needle apparatus into the host cell’s membrane and 
cytoplasm (or into the extracellular environment).  After secretion activation, IpaB 
is secreted into a position within the host cell membrane followed by IpaC.  
These proteins act as early effectors of Shigella invasion.  These two proteins 
associate within the host cell membrane where they form a translocon pore that 
allows other (later) effector proteins to pass directly into the host cell’s cytoplasm 
where they can contribute to bacterial invasion (Davis et al., 1998) (Blocker et al., 
1999).  Without the translocon pore inserted on the basolateral face, S. flexneri 
cannot enter the host cell (Menard et al., 1993).  To prevent premature secretion 





where they are bound to the chaperone IpgC.  As part of this complex, they are 
stored until the specific signals to be secreted by the TTSS  are received by the 
bacterium (Menard et al., 1993) (Menard et al., 1994) (Page et al., 1999). 
 
IpaB  
 IpaB is a large translocator/effector molecule that possesses multiple 
functions and is secreted by the TTSS of Shigella flexneri.  Its functions include 
directing apoptosis (pyroptosis) in macrophages as a secreted effector and as a 
translocon structural protein through its interaction with IpaC.  The translocon 
pore is inserted into the host cell’s membrane to allow additional effector proteins 
to be directly secreted into the host cell’s cytoplasm (Menard et al., 1994) 
(Zychlinsky et al., 1994) (Blocker et al., 1999).  There is currently no structural 
information available for IpaB and this is mostly due to its large molecular size 
(62 kDa) and hydrophobic nature (Birket et al., 2007).  The entire amino acid 
sequence of IpaB, 580 residues, has been divided into predicted regions based 
on protein structure algorithms, some functional data, and the known structure of 
IpaD to which it has been compared (W.L. Picking unpublished 
observations)(Guichon et al., 2001).  Based on experimental data and predicted 
protein properties, IpaB can be divided into six regions.  These regions include a 
N-terminal helix-turn-helix, two regions that form a dimeric coiled-coil, two 
transmembrane helices and a region predicted to lie on  
the inner face of the host cell membrane (Figure 3.1).  Guichon et al. performed 




stopped with the introduction of large deletions within the N-terminus (Guichon et 
al., 2001).  Guichen et al. also determined that expression of IpaB was not 
impaired when large deletions were introduced within the C-terminus, however, a 
significant decrease in (or total loss of) invasiveness, cell cytotoxicity and 
phagosomal escape was seen (Guichon et al., 2001).  They also introduced 
small deletions within the putative transmembrane region, many of which had 
little effect on protein function or expression when compared to the wildtype 
(Guichon et al., 2001).  They did find one deletion that had a significant effect on 
protein function and expression which consisted of amino acids 307-316, and are 
the seven amino acids immediately preceding the transmembrane/hydrophobic 
region and the first three amino acids of the region (Guichon et al., 2001).  When 
expressed in S. flexneri, the mutant 307-316, had significantly less expression of 
IpaB, it was unable to lyse the phagosome or induce macrophage cell death 
(Guichon et al., 2001).  Their results indicated that the binding site for caspase 1 
is contained in the hydrophobic region, as a mutant lacking amino acids 311-580 
was unable to bind caspase 1, however, a mutant with amino acids 307-316 
deleted was able to bind caspase 1 but could not induce macrophage apoptosis 
(Guichon et al., 2001).  The worked performed by Guichon et al. demonstrates 
that IpaB’s N-terminal is necessary for stable expression and function of the 
protein, the hydrophobic region is needed to maintain function of IpaB or to keep 
other domains in a proper confirmation for expression, and that IpaB binding of 
caspase 1 alone is not sufficient to induce macrophage apoptosis but is only the 
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Figure 3.1 Predicted IpaB Organizational Map 
This organizational map is based on the known structure of IpaD (Wendy 











IpaB’s Interaction with IpgC 
 Before IpaB is secreted by the Shigella TTSS, it waits in the bacterial 
cytoplasm bound to its molecular chaperone IpgC (Birket et al., 2007).  IpgC is a 
class two molecular chaperone specific for binding both IpaB and IpaC (Birket et 
al., 2007).  By binding to IpaB and IpaC, IpgC prevents the degradation of the 
two translocator proteins that would result if these two pore components became 
associated while still in the bacterial cytoplasm (prior to secretion).  It is also 
thought that IpgC is responsible for maintaining IpaB in a state of readiness for 
secretion through the TTSS needle apparatus (Page et al., 1999).  After release 
from IpaB and IpaC, IpgC then binds to the transcription activator mxiE to allow 
the expression of later effector proteins that are injected into the host cytoplasm 
following bacterial invasion (Mavris et al., 2002). 
 
Circular Dichrosim Spectroscopic Analysis of IpB/IpgC and IpaB 
 Circular dichrosim (CD) spectroscopy can be used to determine the 
overall secondary structure of a protein.  It uses circularly polarized light and 
measures the differences in the absorption of left and right handed polarized light 
(Whitmore and Wallace, 2004).  CD spectroscopy utilizes the “far-UV” spectral 
region (190-250 nm) to determine information about the global secondary 
structure (Whitmore and Wallace, 2004) (Espina et al., 2007).  Using this 
wavelength region, the peptide bond serves as the chromophore exhibiting 




(Whitmore and Wallace, 2004).  This method allows the type and amount of 
secondary structure a protein contains to be determined because these different 
secondary structures (including alpha-helix, beta-sheet, and random coil) have a 
characteristic CD spectrum.  This method cannot, however, be used to determine 
the specific residues involved in any of the three aforementioned types of 
secondary structure within a protein.  CD analysis of IpaB/IpgC and IpaB alone 
(performed by N. Darboe) reveals that IpgC has a significant effect on the 
secondary structure of IpaB (Figure 3.2).  Both IpaB/IpgC and IpaB alone have 
significant alpha-helical structure supported by the characteristic minima at 208 
and 223 nm.  While the IpaB/IpgC complex is slightly more structured (more α-
helical) when compared to IpaB alone, IpgC is not necessary for IpaB to matain 
its structure. 
 
Fourier Transform Infrared Spectroscopy 
 Fourier transform infrared spectroscopy (FTIR) can be used to determine 
the types of chemical bonds a sample contains by creating an infrared absorption 
spectrum (Espina et al., 2007).  It does this by measuring the specific 
wavelengths absorbed when a sample is exposed to infrared radiation 
(Gallagher, 2005).  FTIR analysis of IpaB (performed by C. Olsen) displayed a 
characteristic pattern consistent with a protein having a dimeric coiled-coil 
(Figure 3.3).  These data, along with the CD analysis, support the hypothesis that 




















Figure 3.2 CD Spectra of IpaB/IpgC and IpaB 
This CD spectrum shows both IpaB (filled circles) and IpaB/IpgC complex 
(unfilled circles) have significant alpha helical components with characteristic 













































Figure 3.3 Fourier Transform Infrared (FTIR) Spectrum of IpaB 
The IpaB FTIR spectrum has the characteristics of a protein with a dimeric 











 In this study, fluorescence spectroscopy was utilized to ascertain the 
effects of IpgC binding on IpaB and to make a first ever attempt at determining a 
topological map for Trp residues within the protein.  Tryptophan scanning 
mutagenesis has been utilized previously to efficiently determine the effect of 
IpgC binding on IpaC.  We have utilized these same techniques to better define 
regions of IpaB that are affected by the binding of IpgC along with its secondary 
structure and topology.  Because so little structural information is available for 





Construction of Insertion Mutants 
 Previously, members of the lab have used tryptophan scanning 
mutagenesis to characterize the effects on the structure and the 
microenvironments of regions of IpaC following protien binding to liposomes and 
to the IpgC chaperone (Harrington et al., 2006) (Birket et al., 2007).  For proteins 
containing only a single Trp residue, Trp scanning mutagenesis exploits the 
natural environmental sensitivity of the single indole group of the Trp to gain 
information on its local surroundings.  Trp fluorescence is highly sensitive to the 
polarity of the environment immediately around it.  This method allows 
fluorescence differences for a protein in two different states to be analyzed for 












 N-Terminal Helix-turn-helix 
 Dimeric Coiled Coil 
 Transmembrane Helices 
 Region predicted to lie on the inner face of the host cell membrane 
 
Figure 3.4 Predicted IpaB Organizational Map 
This organizational map based on the known structure of IpaD shows the 
predicted regions of IpaB and the placement of the single Trp insertion mutants 
with the native Trp at residue 105 and the single Cys at residue 309 labeled 












case, the influence of IpgC binding to IpaB can be used to determine how 
complex formation affects specific regions within IpaB (whereever a Trp residue 
has been inserted). 
 Trp scanning mutagenesis with fluorescence characterization of the 
resulting mutant requires that the protein possess only a single tryptophan.  
Wildtype ipaB contains a single Trp residue residing at position 105 (Figure 3.4).  
In previous studies with IpaC it was convenient that the protein does not have a 
natural Trp so one could simple be inserted any where (Birket et al., 2007).  A 
library of IpaC mutants having only a single Trp were thus made by inserting a 
Trp at perceived key positions (Birket et al., 2007).  The lack of a natural Trp 
made the creation of point mutations in IpaC easy (Birket et al., 2007). 
 The natural Trp of IpaB at residue 105 allowed for the N-terminal region to 
be characterized.  Before other regions could be studied, however, this natural 
Trp needed to be removed.  A knockout mutant was thus created with the natural 
Trp at residue 105 replaced with a phenylalanine (Phe).  The remaining point 
mutations were based on this W105F IpaB mutant template (IpaB ΔW). 
 Site-directed mutagenesis was used to generate 12 mutants that 
contained single Trp residues spanning the length of IpaB.  This allowed the use 
of fluorescence spectroscopy to characterize the entire length of the protein 
(Picking et al., 1996).  In addition to the natural Trp at residue 105, mutants were 
generated that had individual Trp residues introduced at positions 81, 119, 133, 
169, 227, 275, 293, 382, 446, 514, and 553.  Positions 81, 105 and 119 are in 


















         TATTT 
F275W B96f-GAGAGAGAGCTTAAGAATGATCTGGCTCTATGGCAGTCTCTC 




         TCTC 
F382W B100f-GAGAGAGAGCTCGAGGGCTTGGGCGTCGATC 
B101r-GAGAGAGAGCTCGAGCATTTTTGTCCATGCATCTGAAAGG 





           AACAC 
F514W B106f-GAGAGAGAGGCTAGCGACAAATCTAGCAGACCT 
B107r-GAGAGAGAGGCTAGCGCTGTTCTGCCAAACAGCAGAAGCGA 
           CACT 
I553W B108f-GAGAGAGAGAGATCTATTAGCCTCAATGT 
B109r-GAGAGAGAGAGATCTGCCCATACTTCCTGCAATTGGC 
Table 3.1 Table of Primers 








are located in the predicted dimeric coiled-coil.  Positions 227, 275, 293, 446, 
471, and 514 are contained in the predicted transmembrane helices.  The final 
mutant contained a Trp at position 382 which is within the region predicted to lie 
on the inner face of the host cell membrane following insertion of the pore by the 
bacterium.  The specific primers used to generate these mutants are listed in 
Table 3.1.  These were double mutants made using the point mutation W105F as 
a template to ensure each mutant had a lone Trp residue.  In order to minimize 
changes in IpaB’s structure and function, the amino acids most often targeted for 
mutagenesis contained bulky side chains and were non-polar (hydrophobic), 
including leucine, isoleucine, tyrosine and phenylalanine. 
 
Analysis of Trp Replacement Using Invasion and Hemolysis Assays 
 Invasion and contact-mediated hemolysis assays were performed to 
determine the effects of replacing the native Trp and introducing Trp residues 
into other regions within IpaB.  Invasion is a measure of the bacteria’s ability to 
invade a host cell while contact-mediated hemolysis is a measure of the 
bacterium’s ability to form a translocon pore and insert it into the host cell 
membrane.   
 The results for invasion and hemolysis for the S. flexneri strain SF620 
expressing wildtype IpaB were used to provide a baseline of activity for 
comparison with all the mutants created to determine if the specific mutation had 
an effect of the function of IpaB.  As is reported in Table 3.2, the wildtype IpaB 











Trp Mutant  Relative Invasion, % Contact Hemolysis, % 
IpaB/IpgC 100 100 
IpaB ΔW/IpgC 89 95 
IpaB L79W/IpgC 280 82.20 
IpaB F119W/IpgC 106 89.70 
IpaB L133W/IpgC 0 83.50 
IpaB D169W/IpgC 98 78.90 
IpaB F227W/IpgC 0 65.50 
IpaB F275W/IpgC 0 0 
IpaB Y293W/IpgC 0 0 
IpaB F382W/IpgC 0 1.40 
IpaB I446W/IpgC 17 13. 
IpaB F471W/IpgC 0 37.40 
IpaB F514W/IpgC ND ND 
IpaB I553W/IpgC 0 0 
Table 3.2 Functional Analysis of the IpaB Single Trp Mutants Produced in 
S. flexneri 
A significant change was determined to be less than 50% of the wildtype 
IpaB/IpgC invasiveness and hemolysis results.  All results were within 10-15% of 
the results given in the table.  ND-No data available due to the construct not 











of the wildtype IpaB value were determined to be a significant decrease.  IpaB 
ΔW with the native Trp removed, did not show a significant decrease in 
invasiveness or hemolysis, 89% and 95%, respectively.  This shows that the 
removal of the native Trp at residue 105 and its replacement with Phe had little 
negative effect on the function of IpaB.  These results demonstrated that the IpaB 
ΔW mutant could then be used as a template to make other mutants by inserting 
a Trp at different locations. 
 The invasion and hemolysis assays were performed on the twelve 
mutants created (Table 3.2).  Three of the mutants, L79W, F119W and D169W, 
showed no significant decrease in invasiveness, while L79W and F119W showed 
an increase in invasiveness.  Most of the mutants, F227W, F275W, Y293W, 
F382W, I446W, F471W and I553W, showed zero invasiveness with I446W 
having only 17% invasiveness.  The mutants L79W, F119W, L133W, D169W and 
F22W did not have a significant decrease in hemolysis.  The remaining mutants, 
F275W, Y293W, F382W, I446W, F471W and I553 all had significant decreases 
in hemolysis with three mutants, F275W, Y293W and I553W having zero 
hemolysis activity.  These results suggest that some of the mutations in IpaB 
have little to no impact on its function but some of the insertions do have a 
significant impact of the invasiveness and hemolysis of IpaB, however they have 
not significantly changed the overall structure of the protein.  Invasion and 
hemolysis data are not available for F514W due to a problem with the construct 




 Three of the mutants, F227W, I446W and F514W, had problems with 
transformation and expression based on western blot analysis (data not shown).  
It was determined that there had been a problem in the original transformation as 
the three mutants were not producing protein when the cultures were grown.  
These three mutants were retransformed and thought to produce protein, 
however, after analysis of the sodium dodecyl sulfate-polyacrylamide gel 
electrophoresis (SDS-PAGE) gels, it was determined that the bands on these 
three gels were not the right size to be IpaB (62 kDa).  Thus, it was determined 
that there was again a problem with the expression of these three mutants and 
that any data collected before this problem was identified should be discarded.  It 
was also decided these three mutants would not be used in the fluorescence 
experiments that follow. 
 
Tryptophan Emission Maxima Fluorescence 
 Recombinant IpaB was purified with IpgC as a soluble complex in E. coli 
as was previously done with IpaC/IpgC (Birket et al., 2007).  To better 
characterize key regions within IpaB and determine regions that might undergo a 
significant conformational change upon release from IpgC or which might 
physically interact with IpgC, Trp scanning mutagenesis was performed to allow 
comparison of the emission properties of the IpaB/IpgC complex with IpaB alone 
for the wildtype protein and nine mutants.  For this experiment, the wildtype IpaB 
as well as the nine mutants with His-tag labeled IpaB were grown in 1L cultures 




inoculated with isopropyl-thio-2-D-galactopyranoside (IPTG) to induce protein 
production (Page et al, 1999).  IPTG is a non-metabolized lac-inducer added to 
cultures to induce recombinant protein expression when the gene is under the 
control of a lac promoter (Page et al., 1999).  This method allows for the 
production of large amounts of protein that can be subsequently harvested and 
purified (Page et al., 1999).  This method utilized the Tuner cells to produce the 
recombinant IpaB protein by inducing co-expression of the IpaB/IpgC complex.  
After induction with IPTG, the cells continued to shake at 37°C for three hours, at 
which time they are removed and collected by centrifugation at 4000 rpm for 15 
minutes.  The supernatant fraction was discarded and the pellet containing the 
bacteria was resuspended in 40 ml of 1X binding buffer.  The suspension was 
placed in a freezer bottle and stored in a -20°C freezer for later use.  After 
freezing overnight, the suspension was removed and placed in a 37°C water bath 
until completely thawed.  The liquid was then transferred to a beaker on ice to 
prevent the protein from overheating during sonication.  The liquid containing the 
bacteria was sonicated for approximately one minute and thirty seconds per liter 
of original culture grown.  After sonication Ni+ affinity column chromatography 
was used to purify the protein.  The IpaB/IpgC complex bound to the column via 
the His-tag on IpaB while everything else passed through.  The IpaB/IpgC 
complex was then eluted from the column and collected in 1.5 ml fractions.  The 
fractions were then run on a SDS-PAGE gel to determine which fractions 
contained the IpaB/IpgC complex (Figure 3.5).  IpgC’s band is much lower on the 
































Figure 3.5 Purified IpaB/IpgC 
Gels of IpaB/IpgC samples display the IpaB band at approximately 64 kDa and 
the IpgC at approximately 20 kDa.  The SDS-PAGE gel (12%) was stained with 












most IpaB/IpgC complex were pooled to be used for future fluorescence analysis.  
In order to leave as much protein as possible for studying IpaB alone and for 
labeling the Cysteine (Cys) residue in later experiments, only one-fourth of the 
total amount of original culture grown was used for analysis of the IpaB/IpgC 
complex. 
  The remaining three-fourths of the protein preparation was poured over 
the column with the IpaB/IpgC again bound to the Ni+ affinity chromatography 
column.  Before eluting the column, however, binding buffer with 1% OPOE, a 
mild detergent, was added and the column was allowed to sit in a cold room at 
4°C overnight on a rocker plate at half speed.  This was done because the 
IpaB/IpgC complex can be separated in the presence of this detergent (Birket et 
al., 2007).  Hume et al. have shown that IpaB can be purified from IpgC in E. coli 
using a mild detergent (Hume et al., 2003).  After allowing the column to sit 
overnight, it was washed to remove the IpgC that had become separated from 
IpaB.  The column was eluted as before (with imidazole) to collect IpaB fractions.  
This method allowed the collection of IpaB alone due to the His-tag it contains, 
while the free IpgC should pass through the column.  These fractions were also 
run on a SDS-PAGE (12%) gel to determine if the IpgC had been released (Fig. 
3.6).  Theoretically, all the IpgC should be released from the complex and 
contained in the flow through prior to imidazole elution.  A sample of the flow 
through was also run to determine that IpgC had indeed released and was no 
longer complexed with IpaB (data not shown).  After pooling the IpaB only 
































Figure 3.6 Gels of Purified IpaB After Removal of IpgC 
This Commassie-blue stained SDS-PAGE gel shows that the samples contains 











fluorescence labeling and energy transfer studies. 
 Emission maxima values for all of the recombinant IpaB proteins (with and 
without IpgC) are shown in Table 3.3.  For these experiments it was determined 
that a significant change was any wavelength shift equal to or greater than 5 nm 
in either direction, red or blue.  A red shift is a shift to a longer wavelength 
indicating the environment around a specific Trp has become hydrophilic and 
more polar (Sams et al., 1977).  A blue shift is a shift to a shorter wavelength 
indicating the environment around a specific Trp has become more hydrophobic 
and less polar (Sams et al., 1977).  A red shift would indicate movement of the 
residue into a less buried or more exposed state while a blue shift would be due 
to a residue becoming more buried within the structure of the protein.  Both shifts 
could be due to a conformational change of the entire protein or within a specific 
region or microenvironment induced by the binding of IpgC.  If comparing the 
IpaB/IpgC wild type to the IpaB/IpgC mutants or the IpaB only wildtype to the 
IpaB only mutants the shifts are likely due to the environment around the specific 
Trp being different than the native Trp105 
 The purified IpaB/IpgC complex and IpaB alone were both scanned on a 
spectrofluorometer.  Sample graphs displaying emission maximum scans of 
wildtype IpaB complexed with IpgC and wildtype IpaB alone are shown in Figures 
3.7 and 3.8, respectively.  The IpaB/IpgC complex displayed an emission 
maximum of 332 nm while IpaB not bound to IpgC displayed an emission 
maximum of 337 nm.  This shift (of 5 nm) is a significant shift, as previously 




more hydrophilic and more polar in the absence of IpgC.  This could be due to 
IpgC contacting this Trp or the binding of IpgC may induce a conformational 
change in the region that buries the Trp within the protein. 
 The results of all emission maxima scans are shown in Table 3.3.  First, 
the emission maximum of the IpaB only mutants will be compared to the wildtype 
IpaB only emission maximum to determine differences in the environments 
around the inserted Trps.  Of the nine IpaB mutants, eight displayed a spectral 
shift compared to IpaB 105W.  Mutants L79, F275, F382, and I553 all displayed a 
blue shift or a shift to a shorter wavelength compared to the wildtype IpaB only.  
This indicates that the environments around these Trp residues became more 
hydrophobic and less polar compared to the wiltype IpaB only.  Mutants L79, 
F275 and F382 displayed significant shifts of 8 nm, 10 nm, and 15 nm, 
respectively.  This indicates that the microenvironments around these Trp 
residues are more buried within the protein than the native Trp.  The mutants 
F119, D169, Y293, and F471 all displayed a red shift or a shift to a longer 
wavelength, indicating that these Trp residues are in a hydrophilic and more 
polar environment than the native Trp of IpaB only.  Only one, D169, displayed a 
significant red shift of 9 nm.  The region containing this residue is significantly 
less buried than the native Trp.  The mutant L133 did not display a spectral shift 
in either direction, meaning its microenvironment is similar too or the same as the 
microenvironment of the native Trp. 
 Second, the emission maximum of the mutants IpaB/IpgC complexes ill be 




differences in the regions surrounding the inserted Trps.  Four of the IpaB only 
Trp mutants, L79, F275, F382, and I553, displayed a blue shift compared to the 
wildtype IpaB/IpgC complex.  This indicates that the area around these Trp 
residues is more hydrophobic and less polar than the native Trp.  Three of the 
mutants, F275, F322 and I553, displayed a significant shift to a shorter 
wavelength, 5 nm, 10 nm and 8 nm, respectively.  This is likely due to these 
regions being more buried within the structure of the folded protein compared tot 
eh wildtype IpaB/IpgC Trp.   The remaining five mutants, F119, L133, D169, 
Y293, and F471, all displayed a red shift or a shift to a longer wavelength, 
indicating these microenvironments are hydrophilic and less buried relative to the 
native Trp of the IpaB/IpgC complex.  Two of the mutants, F119 and D169 
displayed significant red shifts, 11 nm and 13 nm, respectively.  These shifts are 
likely due to these two regions being significantly more exposed or less buried 
with the structure of the protein relative to the wildtype IpaB/IpgC complex. 
 Third, the emission maximum of the IpaB/IpgC complex will be compared 
to IpaB alone, for each mutant.  Of the nine mutants, only two displayed a 
significant spectral shift.  The remaining seven mutants, L81, F119, L133, D169, 
F275, Y293 and F382, did not display a significant spectral shift when not bound 
to IpgC (Table 3.3).  This indicates that the environments around these Trp 
residues are not significantly altered during IpaB binding with IpgC or they do not 
undergo a conformational change that transforms the environment around these 
particular Trp residues which can be detected by this method.  Both, F471 (7 nm) 









Figure 3.7 Emission Maximum Scan of wildtype IpaB/IpgC Complex  
The wildtype sample was excited at 295 nm and the spectrum collected at a 
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Figure 3.8 Emission Maximum Scan of wildtype IpaB without IpgC 
The wildtype sample was excited at 295 nm and the spectrum collected at a 
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Trp Mutant Emission Maximum, nm 
IpaB/IpgC  332 
IpaB 337 
IpaB L79W/IpgC 328 
IpaB L79W 329 
IpaB F119W/IpgC 343 
IpaB F119W 341 
IpaB L133W/IpgC 336 
IpaB L133W 337 
IpaB D169W/IpgC 345 
IpaB D169W 346 
IpaB F275W/IpgC 327 
IpaB F275W 327 
IpaB Y293W/IpgC 335 
IpaB Y293W 339 
IpaB F382W/IpgC 322 
IpaB F382W 322 
IpaB F471W/IpgC 334 
IpaB F471W 341 
IpaB I553W/IpgC  324 
IpaB I553W 333 
Table 3.3 Mutational Characteristics of Single Trp Mutants 
This table lists the emission maximum for each individual sample.  A 
significant shift was considered to be any shift of 5 nm or more in 












previously stated the wildtype IpaB (W105) also displayed a significant shift upon 
IpaB binding (5 nm, as shown in Table 3.3).  It is interesting to note that all three 
displayed a red shift upon removal of IpgC, indicating the environment around 
these Trp residues became more polar and hydrophilic.  These data suggest that 
these three residues, or the specific regions containing them, may be either 
directly involved in binding IpgC or the region undergoes a significant and 
detectable conformational change exposing the environments making them 
hydrophilic which results in the observed change in Trp fluorescence.  The 
wildtype IpaB has a Trp at residue 105 and lies in the predicted N-terminal helix-
turn-helix region.  F471 resides in the predicted transmembrane helix nearest the 
C-terminal.  I553 is contained in the second or C-terminal coil of the predicted 
dimeric coiled-coil.  We speculate that IpgC may interact with IpaB at these areas 
to maintain it in a secretion ready state, however, we cannot rule out that these 
regions undergo a conformational change after dissociation from IpgC either to 
pass through the narrow inner channel of the TTSA needle, to prepare for 
binding/interaction with IpaC, or to assume an active effector state. The 
fluorescence method used here is well suited for determining information about 
the environments immediately surrounding Trp residues, but it does not provide a 
global picture of the effects of the binding of a chaperone to its cognate protein.  
 
Thermal Unfolding Analysis of IpaB/IpgC and IpaB 
 To determine the effect of IpgC binding on the thermal stability of the 




analyses were performed.  As with the emission maxima determinations, this 
method does not provide a global picture of the protein’s stability or total protein 
unfolding, but rather the unfolding temperature of the area immediately 
surrounding the single Trp residue.  The proteins used for these experiments 
were from the same samples that were used for the emission maxima scanning 
analyses.  This ensured that the results seen or conclusions made, for these 
experiments, could be compared to the emission maxima data. 
 A sample series of temperature-dependent scans displays a single line for 
each temperature increment (2.5°C/scan) scanned from 305 nm to 400 nm.  The 
temperature range scanned was from 10°C to 90°C (Figure 3.9).  These data 
were then analyzed to determine the wavelength with the highest intensity 
(emission maximum).  This wavelength was then graphed as a function of 
sample temperature (Figure 3.10).   
 The Tm given in this study is not a conventional Tm, as it is not referring to 
the unfolding of the entire protein, but rather the initial temperature at which the 
specific environment directly around a particular Trp residue begins to unfold.  As 
with the emission maxima studies, this method is useful due to the natural 
fluorescent properties of the indole group contained in the Trp, which is directly 
influenced by its environment.  First, the Tm of each IpaB only mutant will be 
compared to the Tm of the wildtype IpaB only Trp to determine difference in 
thermal stability of the regions containing a Trp.  The wildtype 105W, without 
IpgC, has a Tm of 47°C (Table 3.4).  When compared to the mutants without 









Figure 3.9 Initial Thermal Unfolding Graph of wildtype IpaB/IpgC Complex 
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Figure 3.10 Thermal Unfolding Graph of wildtype IpaB/IpgC as a Function 
of Sample Temperature 
The arrow shows the selected “transition” temperature which is considered the 































Trp Mutant Melting Temp.  (Tm), °C ΔTma, °C 
IpaB/IpgC  61  
IpaB 47 -14 
IpaB L79W/IpgC 68  
IpaB L79W 54 -14 
IpaB F119W/IpgC 72.5  
IpaB F119W 55 -17.5 
IpaB L133W/IpgC 66  
IpaB L133W 44 -22 
IpaB D169W/IpgC 65  
IpaB D169W 52.5 -12.5 
IpaB F275W/IpgC 55  
IpaB F275W 50 -5 
IpaB Y293W/IpgC 52.5  
IpaB Y293W 52 -0.5 
IpaB F382W/IpgC 70  
IpaB F382W 55 -15 
IpaB F471W/IpgC 65  
IpaB F471W 55 -10 
IpaB I553W/IpgC  54  
IpaB I553W 65 +9 
Table 3.4 Thermal Unfolding of IpaB/IpgC Complex and IpaB Alone 
Tm is not the melting point of the entire protein, but the point at which the 
environment around a specific Trp begins to unfold.  a-Change in Tm of IpaB 










before the region containing the native Trp.  The other eight mutants all unfold at 
higher temperatures compared to the wildtype IpaB only, indicating that the area 
around these Trp residues unfolds later than the area around the native Trp. 
 Second the Tm of each mutant IpaB/IpgC complex will be compared to the 
Tm  of the wildtype IpaB/IpgC complex to determine difference in the thermal 
stability of the regions that contain a Trp.  The wildtype 105W IpaB/IpgC complex 
had a Tm of 61°C.  When this result is compared to the IpaB/IpgC mutants, F275, 
Y293 and I553 display a lower Tm, indicating these three regions unfold before 
the region around the native Trp.  The other six mutants displayed higher melting 
temperatures than the wildtype IpaB/IpgC complex, indicating that the regions 
containing those Trp residues unfold later than the region surrounding the native 
Trp.   
 Third, the Tm of the IpaB/IpgC complex will be compared to the Tm of IpaB 
only for each pair.   The higher melting temperature of the wildtype IpaB/IpgC 
complex (61°C) compared to the Tm of the wildtype IpaB only (47°C) indicates 
that the region containing the native Trp in the IpaB/IpgC complex is more 
thermally stable when bound to IpgC than when not bound.  Comparing the Tm of 
each mutant IpaB/IpgC complex to the Tm of its corresponding IpaB only 
mutants, eight had a higher Tm when bound to IpgC (Table 3.4).  This indicates 
that the regions around these eight Trp residues are more stable and unfold at a 
higher temperature when IpaB is bound to IpgC.  These data indicate that the 




 One of the mutants, I553W, was the only sample in which the IpaB/IpgC 
complex was less thermally stable when compared to its corresponding IpaB only 
mutant.  The I553W complex had an initial unfolding temperature of 54°C.  
I553W IpaB only had an initial unfolding temperature of 65°C, 11°C higher than 
its IpaB/IpgC complex.  This Trp resides on the C-terminal coil or the second coil 
of the predicted dimeric coiled-coil.  A possible reason for this decreased Tm is 
that the conformation imposed by the binding of IpgC on this region, which may 
be required for effective binding to IpgC, is less stable than the conformation 
when IpaB is ready to be secreted or interact with IpaC to form the translocon 
pore. 
 Three of the samples, wildtype IpaB, F471W and I553W, that displayed a 
significant temperature change when comparing the Tm of the IpaB/IpgC complex 
to IpaB alone, also displayed a significant shift in emission maximum when 
comparing their IpaB/IpgC complex to IpaB only.  Wildtype IpaB is located in the 
predicted N-terminal helix-turn-helix; F471W is in the predicted transmembrane 
region nearest the C-terminus, while I553W is in the second coil of the dimeric 
coiled-coil.  The large shifts seen at all three of these positions may indicate that 
the area around these three Trp residues might be heavily involved in the binding 
of IpgC, or may undergo a significant conformational change to facilitate the 
binding of IpgC.  It is interesting to note that the two mutants with the largest 
change in initial unfolding temperature (Tm), F119W (-17.5°C) and L133W (-
22°C), did not display a significant emission maximum shift, 2 nm blue shift and 1 




stabilized by the binding of IpgC but they do not undergo a significant 
conformational change due to binding of IpgC.   
 Overall, the stability of the environments around the individual Trp 
residues is greater when IpaB is bound to its chaperone IpgC.  These results 
were not entirely unexpected, since previous CD studies indicated that the 
IpaB/IpgC and the IpaC/IpgC complexes are more thermally stable compared to 
IpaB or IpaC alone (Birket et al., 2007).  However, CD spectroscopy measures 
global secondary structure while the fluorescence of a single Trp residue 
provides a snapshot of only a small microenvironment within the whole protein.  
In all samples but one, a significant Tm change was seen, which may indicate 
that all of these environments undergo a conformational change when bound to 
IpgC, increasing the amount of α-helices and β-sheets as shown by CD analysis, 
thereby increasing the thermal stability of the area around a single Trp and the 
protein as a whole (Birket et al., 2007). 
 
Förster Resonance Energy Transfer 
 Förster resonance energy transfer (FRET) is the nonradiative transfer of 
energy between a pair of fluorophores.  After determining the amount of energy 
transferred from a donor to an acceptor it is possible to calculate the distance 
between the two fluorophores.  When measuring the fluorescence of a single 
fluorophore, it is excited at a wavelength within its absorbance spectrum and it 
releases the absorbed energy as fluorescent light over a characteristic emission 




emission spectrum of the first (donor) fluorophore, the excitation energy of the 
first can be passed to the second (acceptor) without the release of a photon. This 
is a distance-dependent phenomenon and FRET results in decreased 
(quenched) fluorescence of the donor probe.   
 To properly utilize FRET, it is important to determine the two fluorophores 
that will be used.  The donor fluorophore emission spectrum must overlap with 
the excitation spectrum of the acceptor fluorophore (see Figure 3.11).  The donor 
fluorophore can then be excited at a wavelength specific to it and not the 
acceptor fluorophore.  In the absence of an acceptor probe, the donor will have a 
measurable amount of fluorescence.  The fluorescence of the donor only sample 
is than compared to the fluorescence of the same donor in the presence of the 
acceptor (donor/acceptor sample).  Decreased donor fluorescence intensity 
(quenching) will be seen as an increase in the donor/acceptor spectrum intensity, 
however, it is the donor quenching that is used to quantify FRET. 
 The donor probe in these experiments is the single Trp present in the 
wildtype or the mutant described above.  To introduce an acceptor probe, the 
native single Cysteine (Cys) of IpaB at position 309 was labeled with a sufhydral 
reactive fluorophore.  We chose to use 5-[2-[(2-Iodo-1-oxoethyl)amino] 
ethylamino]-1-naphthalenesulfonic acid (IAEDANS), to label Cys309.  Cys309 is 
located at the end of the predicted first transmembrane helix.  Because we know 
the positions of the newly introduced Trp residues we should be able to use 
FRET to determine a series of intramolecular distances to provide preliminary 












Figure 3.11 Principles of FRET 
The donor emission fluorescence must overlap with the absorbance of the 











 Figure 3.12 displays the emission spectrum of wildtype IpaB consisting of 
the IpaB donor only sample (solid blue line) and the IpaB donor/acceptor (dashed 
red line) sample with the difference in FRET marked with an arrow.  Results of all 
FRET spectra are shown in Table 3.5.  To calculate the percent energy 
transferred between FRET pairs, the equation 
(1-Fda/Fd) X 100 
was used, where Fd is the fluorescence emission maximum wavelength of the 
donor only sample and Fda is the fluorescence emission of the donor/acceptor 
sample at the same wavelength as the donor only sample.  To calculate the 
distance between the two fluorophores, we used the equation  
E=Ro6/(Ro6 + R6) 
where E equals the amount of energy transferred Ro is the theoretical distance 
that would give 50% FRET (Ro =  22Å for the Trp-AEDANS), and R equals the 
actual distance between the donor and acceptor in Å (Lakowicz, 2006).  The 
distance measured was the distance from the Trp to the AEDANS molecule on 
Cys309, not directly to the Cys which introduces a modest amount of uncertainty 
to these distance calculations. 
 As can be seen in Table 3.5, all but one FRET pair had an amount of 
energy transfer between 50% and 90%.  Only one sample had less than 50% 
energy transfer, IpaB F382W with 10.56%.  F382W is located in the region 
predicted to lie on the inner face of the host cell membrane only 73 residues from 
Cys309.  The data suggest this Trp at 382 is farther from the Cys309 than any of 




distances ranging from 15.44Å to 21.93Å.  These data support the hypothesis 
that IpaB is a highly ordered molecule with a compact structure.  We are still 





























Figure 3.12  FRET Spectrum of wildtype IpaB 
The emission spectrum of Trp is shown in the absence (solid blue line) and 
presence (dashed red line) of AEDANS acceptor.  The black arrow shows the 
decrease in emission maximum for the IpaB donor/acceptor protein compared to 
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Protein Energy Transfer (%) Calculated Distance (Å) 
IpaB L79W 87.34 15.95 
IpaB 105W 53.15 21.54 
IpaB F119W 60.67 20.47 
IpaB F133W 78.17 17.79 
IpaB D169W 79.98 17.46 
IpaB F275W 68.66 19.30 
IpaB Y293W 89.32 15.44 
IpaB F382W 10.56 31.41 
IpaB F471W 89.18 15.48 
IpaB I553W 50.49 21.93 
Table 3.5 FRET of IpaB Trp Mutations 
The percent energy transferred and calculated distance for each pair.  The pairs 














DISCUSSION AND FUTURE PLANS 
 
 
 Shigella flexneri is the causative agent of shigellosis, a severe 
gastrointestinal disorder that is also called bacillary dysentery.  It affects millions 
of people around the world every year.  It is transmitted via the fecal-oral route 
and infects humans by invading the colonic epithelium.  Once the bacterium has 
reached the colon, it takes advantage of microfold cells (M cells) that sample the 
environment of the colon to cross the epithelial layer (Owen, 1986).  After entry, 
the bacterium is ingested by macrophages that are then induced to undergo 
apoptosis as S. flexneri secretes IpaB as an effector into their cytoplasm.  S. 
flexneri is then released at the basal side of the epithelium, where it can then use 
its type III secretion system (TTSS) to induce ruffling of the host epithelial cells 
which leads to pathogen uptake by these cells.  Shigella then escapes the 
resulting phagosome and grows in the host cell cytoplasm. 
IpaB is secreted by the Shigella TTSS to act as a structural protein, via 
interactions with IpaC, in the formation of a pore in the host cell membrane 





cytoplasm to induce pathogen entry.  Without IpaB, S. flexneri cannot escape the 
macrophage or form the pore to inject the effectors that induce cell ruffling in 
epithelial cells.  Little research has been done that focuses on IpaB’s structure.  I 
hypothesize that IpaB is a highly structured and complex molecule, with and 
without its secretion chaperone IpgC, and that it is thermally more stable when 
bound to IpgC due to the stabilized conformation induced by its interaction with 
the IpgC chaperone.  Tryptophan (Trp) scanning mutagenesis was used to better 
characterize the influence of IpgC on IpaB’s structure.  This hypothesis is 
supported by the data collected here and by FTIR and CD spectroscopy data that 
were performed elsewhere and generously made available for inclusion in this 
thesis.  These data support the notion that IpaB has an intrinsic (intramolecular) 
dimeric coiled-coil and a significant α-helical structure. 
 This study focused on understanding the interactions of IpaB with its 
molecular chaperone, IpgC, and the structural effects imposed by the binding of 
IpgC by utilizing Trp scanning mutagenesis.  Without its chaperone, IpaB could 
be lost or degraded prior to its secretion from Shigella as an effector or for 
formation of the translocon pore.  This fluorescence study is possible because 
Trp has natural fluorescence properties that are greatly influenced by the 
immediate environment surrounding it.  This approach allows monitoring of the 
microenvironments surrounding strategically-placed Trp residues within IpaB.  By 
creating a library of single Trp containing point mutations we can study multiple 
regions throughout the length of the protein using the fluorescence properties of 




and contact-hemolysis functions to determine if the mutations affected the 
function of the IpaB protein.  The ΔW IpaB had the native Trp at residue 105 
removed and replaced with phenylalanine (Phe).  It showed no significant 
decrease in invasiveness or hemolysis suggesting that replacement of the 
original Trp does not affect the function of the protein.  ΔW IpaB was not used for 
any fluorescence experiments since it lacks any Trp.  The same functional 
assays were performed on all the single Trp mutants to determine the effect of 
the single Trp insertions on the function of the protein.  Some displayed levels 
similar to the wildtype while several others displayed a decrease in virulence 
functions, which suggest that some of the residues replaced are needed for 
proper function of the protein.  Overall these data suggest that the native Trp can 
be replaced and reintroduced in other locations without adversely affecting the 
IpaB’s function.  Insertions between residues 1 and 227 did not display a 
significant decrease in contact-mediated hemolysis while all the insertions past 
residue 227 displayed a significant decrease in hemolysis.  This indicates that 
residues necessary for proper formation of the IpaB part of the translocon pore 
are located between 228 and 580.  A similar result is seen for the invasion of 
cultured cells.  These data may indicate that the portion of IpaB that is necessary 
for proper invasion is located in the transmembrane helices, the region that lies 
on the inner face of the host cell or the C-terminal coil of the dimeric coiled-coil.  
Three of the insertion mutants, F227W, I446W and F514W, were not found to 




used in subsequent experiments using purified IpaB.  These three constructs will 
need to be remade in future studies. 
 To examine what is occurring at the protein level for these different IpaB 
mutants, the wildtype and single Trp mutant proteins were co-expressed with 
their IpgC chaperone in E. coli BL21 (DE3).  They were then purified by Ni++ 
affinity chromatography using a His-tag located at the N-terminus of IpaB.  IpaB 
was then separated from its chaperone IpgC using a mild detergent to study the 
effect of IpgC binding on IpaB’s structure and functional properties.  To 
determine areas that might be important for binding/interacting with IpgC the 
emission maximum of the various Trp residues in the IpaB/IpgC complex were 
compared to IpaB alone.  Three comparisons were made, including a) comparing 
the emission maximum of the wildtype IpaB/IpgC complex to IpaB alone, b) the 
mutant IpaB/IpgC complex to the wildtype IpaB/IpgC complex, and c) comparing 
the IpaB only mutants to the IpaB only wildtype.  In many cases, the Trp residues 
displayed a spectral shift to either the red or the blue during these comparisons.  
In some cases they displayed a significant spectral shift or a shift equal to or 
greater than 5 nm.  Blue shifts in Trp residues indicate that the regions containing 
the Trp are becoming more hydrophobic (less polar) than the Trp to which it is 
being compared, possibly meaning the residues are more buried within the 
protein.  Red spectral shifts indicate that the regions have become hydrophilic 
(more polar), possible meaning the residues are less buried or more exposed to 
the surrounding solvent.  The reason for these shifts is likely due to either direct 




change induced by the binding of IpgC.  We know IpgC is one third the size of 
IpaB.  It is likely that IpgC induces IpaB to unfold or become less compact for 
proper binding, thus altering solvent exposure for some of the residues. 
 The emission maxima data also allow us to determine changes in the Trp-
containing regions relative to the native Trp at residue 105.  This includes 
whether these residues become more hydrophobic or hydrophilic (more or less 
polar) and whether they are more or less buried/exposed within the structure of 
IpaB.  Relative to the native Trp105, we are able to say that residue L79 is more 
hydrophobic and more buried, F119 is very hydrophilic and more exposed, L133 
is hydrophilic and more exposed, D169 is very hydrophilic and more exposed, 
F275 is more hydrophobic and less buried, Y293 is hydrophilic and more 
exposed, F382 is very hydrophobic and more buried, F471 is hydrophilic and 
more exposed, and I553 is hydrophobic and more buried with in the structure of 
IpaB.  Most of the residues located near the transition between regions appear to 
be more exposed while the residues that lie in the interior of the predicted 
regions or the interior of the helices are more buried within the protein. 
 Fluorescence thermal unfolding analyses were used to monitor the 
stability of the various microenvironments containing the Trp residues and to 
demonstrate that most of the regions of IpaB are more thermally stable when 
bound to IpgC than when not bound to IpgC.  The lone exception to this turned 
out to be I553W, whose lower Tm when bound to IpgC may be due to the 
conformation imposed on the region by IpgC binding (which may be necessary 




or a nearby residue with IpgC causes the region to unfold earlier than when it is 
not bound to IpgC.  There does not appear to be any correlation with the change 
in unfolding of a region and its environment with respect to hydrophobicity or 
hydrophilicity.  Both types of environments display large and small thermal shifts 
in either direction.  It does appear that the closer a residue is to a turn or a region 
joining two helices the larger the shift in thermal stability it displays.  The reason 
for this is likely the same as with the emission maxima, that the region between 
the helices is less constrained and more likely to undergo a conformational 
change.   
 Förster resonance energy transfer studies allowed us to determine the 
amount of energy transferred between a specific Trp and the AEDANS, a probe 
linked to Cys309.  This allowed us to calculate the distance between the donor 
and acceptor probes.  Nine of the ten donor/acceptor pairs displayed 50% or 
more energy transfer indicating these Trp residues are 22Å or less away from 
Cys309.  Only one residue appeared to lie further from Cys309 than 22Å.  
F382W appears to lie approximately 32Å away from Cys309, indicating that the 
region predicted to lie on the inner face of the host cell membrane protrudes from 
the protein unlike any of the other regions.  This makes sense as this region is 
predicted to lie on the inner face of the host cell and it would thus need to 
protrude from the rest of the protein.  Once a topological map of IpaB is 
developed using these data, we will be able to determine if IpaB does indeed fold 
similar to IpaD, another S. flexneri TTSS protein whose structure IpaB has been 




 Taken together, these data allow us to identify key regions/areas of IpaB 
induced in interactions with IpgC.  They also lay the groundwork for determining 
the structure of IpaB.  Key regions of IpaB may include the regions containing 
W105, F471 and I553, as each of these mutants displayed a significant spectral 
shift in emission maximum when the wildtype IpaB/IpgC complex was compared 
to the wildtype IpaB alone.  This is expected as the three residues are predicted 
to be located in the loops or turns connecting the helices.  Regions that connect 
helices tend to be more “floppy” or less constrained than the residues located 
within the helices.  All three of these residues also displayed a significant shift in 
thermal stability in response to the binding or interaction with IpgC.  It is 
interesting to note that two of the mutants that displayed a significant shift as a 
result of the binding of IpgC also had a complete loss of invasiveness and 
hemolysis indicating that the regions containing these insertions have undergone 
a change that disrupts the function of the protein.  From the thermal unfolding 
analyses the regions containing F119, D169, Y293, and F382, are likely key 
regions as they undergo the largest shift in thermal stability indicating the binding 
of IpgC may have a greater effect on the conformation of these regions 
compared to the other regions of IpaB. 
 The hypothesis that IpaB is a highly structured and complex molecule that 
is more thermally stable when bound to its chaperone was supported by this 
work.  Future plans would include further mutagenesis of the regions thought to 
be involved in IpgC binding to better characterize these interactions.  The regions 




N-terminal transmembrane helices between residues 170-227 and 228-274, the 
region predicted to lie on the inner face of the host cell membrane between 
residues 311-381, and the C-terminal coil between residues 554-580, because 
these regions appear to be the most affected by the binding of IpgC.  This would 
increase our knowledge of the effects of IpgC binding on these areas.  Cys 
mutants could be also made at the same locations as the Trp insertions, after 
removing and replacing the native Cys309, to allow complementery studies of 
IpaB by utilizing the same fluorescence experiments and measuring the distance 
between the Cys insertions and the wildtype Trp105 to further develop a 
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Scope and Method of Study:  
This study focuses on the secondary structure of invasion plasmid antigen B 
(IpaB) of Shigella flexneri and the effects on it by the binding of invasion 
plasmid gene C (IpgC) along with sites of interaction with IpgC.  IpgC is 
the molecular chaperone of IpaB that is responsible for keeping IpaB from 
associating with invasion plasmid antigen C (IpaC) or degrading before it 
is secreted.  A library of single tryptophan containing mutants was created 
by replacing the native tryptophan (Trp) at position 105 with phenylalanine 
(Phe) and using this as a template to make twelve mutants by inserting 
Trp at places throughout the length of the protein.  Fluorescence 
spectroscopy utilizing the naturally fluorescent properties of Trp was used 
to determine areas of interaction with IpgC and the effects of IpgC’s 
binding on IpaB’s secondary structure and topology. 
 
Findings and Conclusions: 
Invasion and hemolysis assays showed that the native Trp at residue 105 could 
be replaced with Phe and used as a template to make single insertion 
mutants.  The same assays showed that several of the mutants had no 
effect on the protein’s function while some of the mutants showed no 
invasiveness or hemolysis but no significant structural changes.  Three 
mutants were determined to be problematic and their use was 
discontinued.  The emission maximum scans showed that many of the 
mutants were not affected by the binding of IpgC.  Two mutants plus the 
wildtype IpaB displayed significant spectral shifts to the red, indicating that 
the environment around that Trp became more polar (more hydrophilic) 
when not bound to IpgC.  The thermal unfolding analysis showed that 
IpaB was more stable when in complex with IpgC than when alone except 
in one case (for the mutant I553W).  The Förster resonance energy 
transfer (FRET) studies provided information to determine the tertiary 
structure features of IpaB.  These data support the hypothesis that IpaB is 
a highly structured and complex molecule that is more thermally stable 
when bound to its chaperone IpgC. 
